Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
Among patients with hormone-receptor-positive, HER2-negative advanced breast cancer who had sensitivity to previous endocrine therapy, treatment with palbociclib-fulvestrant res...